0001365618-14-000003.txt : 20140922 0001365618-14-000003.hdr.sgml : 20140922 20140922171917 ACCESSION NUMBER: 0001365618-14-000003 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20140918 FILED AS OF DATE: 20140922 DATE AS OF CHANGE: 20140922 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Anacor Pharmaceuticals, Inc. CENTRAL INDEX KEY: 0001411158 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 251854385 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 1020 E. MEADOW CIRCLE CITY: PALO ALTO STATE: CA ZIP: 94303 BUSINESS PHONE: 650-543-7500 MAIL ADDRESS: STREET 1: 1020 E. MEADOW CIRCLE CITY: PALO ALTO STATE: CA ZIP: 94303 FORMER COMPANY: FORMER CONFORMED NAME: Anacor Pharmaceuticals Inc DATE OF NAME CHANGE: 20070830 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Hove Anders D CENTRAL INDEX KEY: 0001365618 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-34973 FILM NUMBER: 141114617 MAIL ADDRESS: STREET 1: 30 ROCKEFELLER PLAZA, SUITE 5508 CITY: NEW YORK STATE: NY ZIP: 10112 4 1 edgar.xml PRIMARY DOCUMENT X0306 4 2014-09-18 0001411158 Anacor Pharmaceuticals, Inc. ANAC 0001365618 Hove Anders D C/O VENROCK 3340 HILLVIEW AVE. PALO ALTO CA 94304 1 0 0 0 Common Stock 2014-09-18 4 S 0 1500 24.87 D 3484035 I By Funds Common Stock 2014-09-19 4 S 0 738500 24.87 D 2745535 I By Funds The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by Venrock Healthcare Capital Partners, L.P. ("VHCP"), VHCP Co-Investment Holdings, LLC ("VHCP Co-Invest"), Venrock Associates IV, L.P. ("VA4"), Venrock Partners, L.P. ("VP") and Venrock Entrepreneurs Fund IV, L.P. ("VEF4") on March 24, 2014. VHCP holds an aggregate of 1,273,482 shares, VHCP Co-Invest holds an aggregate of 232,953 shares, VA4 hold an aggregate of 1,609,767 shares, VP holds an aggregate of 328,281 shares and VEF4 holds an aggregate of 39,552 shares. VHCP Management, LLC ("VHCP Management") is the general partner of VHCP and the manager of VHCP Co-Invest and may be deemed to beneficially own these shares. Venrock Management IV, LLC ("VM4") is the sole general partner of VA4 and may be deemed to beneficially own these shares. Venrock Partners Management, LLC ("VPM") is the sole general partner of VP and may be deemed to beneficially own these shares. VEF Management IV, LLC ("VEFM4") is the sole general partner of VEF4 and may be deemed to beneficially own these shares. Dr. Hove is a managing member of VHCP Management and a member of VM4, VPM and VEFM4 and may be deemed to beneficially own these shares. Dr. Hove, VHCP Management, VM4, VPM and VEFM4 expressly disclaim beneficial ownership over these shares except to the extent of their indirect pecuniary interests therein. VHCP holds an aggregate of 1,003,546 shares, VHCP Co-Invest holds an aggregate of 183,575 shares, VA4 hold an aggregate of 1,268,550 shares, VP holds an aggregate of 258,696 shares and VEF4 holds an aggregate of 31,168 shares. /s/ Anders D. Hove 2014-09-22